Stuart Bussell

VP of Development

Stuart leads process development and product manufacturing activities at Inhibrx, including sub-teams for upstream and downstream process development and analytical and formulation development. His team internally produces and characterizes materials for efficacy, PK, and exploratory and GLP toxicology studies and works with contract organizations for the production and release of materials for clinical studies. Prior to joining Inhibrx, Stuart led teams of engineers and scientists developing novel protein production platforms at Sutro Biopharma and Ambrx and worked on experimental growth factor, antibody, and antibody drug conjugate therapies. Stuart received his Ph.D. in chemical engineering from Cornell University.